Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Suma Krishnan is recorded as COO and Board Member at Krystal Biotech, Inc. (KRYS). The proxy statement of Krystal Biotech, Inc. reports total compensation of $6,948,401 for Suma Krishnan in fiscal 2025, including a base salary of $677,500. Disclosed compensation is on record for 8 fiscal years. Suma Krishnan has spoken on 3 earnings calls across 1 company, most recently for Krystal Biotech, Inc. on August 3, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2016-01-01–present
Proxy statement
Recorded roles and call appearances connecting this person to public companies.
COO, Board Member
2016-01-01–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Krystal Biotech, Inc. (KRYS) | President, R&D | $677,500 | $6,948,401 |
| 2024 | Krystal Biotech, Inc. (KRYS) | President, R&D | $639,167 | $8,243,817 |
| 2023 | Krystal Biotech, Inc. (KRYS) | President, R&D | $575,000 | $3,835,481 |
| 2022 | Krystal Biotech, Inc. (KRYS) | President, R&D | $514,833 | $2,979,559 |
| 2021 | Krystal Biotech, Inc. (KRYS) | President, R&D | $453,359 | $5,123,121 |
| 2020 | Krystal Biotech, Inc. (KRYS) | President, R&D | $392,215 | $602,976 |
| 2019 | Krystal Biotech, Inc. (KRYS) | Chief Operating Officer | $305,642 | $305,642 |
| 2018 | Krystal Biotech, Inc. (KRYS) | Chief Operating Officer | $200,000 | $495,444 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
